Activist Investor Bill Ackman Plays Defense

Activist investor William Ackman, with about $2 billion in losses on Valeant Parmaceuticals, is struggling to salvage his big bet on the drug maker.

from WSJ.com: US Business http://ift.tt/1HagGxk
via IFTTT